Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00764959 · ClinicalTrials.gov registry record
Retrospective Study of the Linear™ Hip
A clinical trial, sponsored by Encore Medical, L.P..
- Terminated
- Registry status
- 200
- Enrollment target
NCT00764959: Clinical Trial study, sponsored by Encore Medical, L.P..
NCT00764959 is a clinical trial that was terminated before completion, run by Encore Medical, L.P.. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00764959 was terminated before completion, sponsored by Encore Medical, L.P..
- TERMINATED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the use and efficacy of the Encore Linear™ Hip System in a group of 200 patients for whom data has already been collected.
Interventions
- DEVICE Encore Linear™ Hip System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2007-10 |
| Est. Completion | 2011-02 |
Why NCT00764959 stopped before completion
NCT00764959 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Encore Linear™ Hip System is the first listed.
NCT00764959 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00764959 about?
NCT00764959 is a clinical study titled "Retrospective Study of the Linear™ Hip". The purpose of this study is to evaluate the use and efficacy of the Encore Linear™ Hip System in a group of 200 patients for whom data has already been collected.
What is the current status of trial NCT00764959?
This trial is currently terminated. The enrollment target is 200 participants. The study started on 2007-10. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00764959?
The interventions under investigation include: Encore Linear™ Hip System (DEVICE).
Who is sponsoring clinical trial NCT00764959?
This trial is sponsored by Encore Medical, L.P., which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia